Aker Biomarine Antarctic as

Aker Biomarine Antartic as

Stefan Hupfeld

Finn Myhren

Tove Jule Evjen

Håvard Thøgersen

The present invention relates to enhanced omega-3 formulations, and in particular to formulations comprising a phospholipid fraction and a triglyceride fraction in combinations with agents that provide a formulation with improved viscosity and dispersion characteristics.

Enhanced omega-3 formulations

Oral capsules have been dismissed as a dosage form for delivery high dosages of krill phospholipids, but by purifying these to high levels it is indeed possible to use this dosage form to deliver, for example, 700 mg or more phospholipids per capsule.

Capsules containing high doses of krill phospholipids

Current krill oil extracts are liquid at room temperature and include only about 45-55% phospholipids. As the purity of phospholipids increases, the extracts become more viscous, making them difficult to handle and process. The invention mixes these pure materials with viscosity-reducing agents to make them amenable to processes such as encapsulation. Thus the invention retains the useful liquid characteristics of known krill extracts while providing much higher concentrations of phospholipids.

Liquid phospholipid-containing compositions for the preparation of pharmaceuticals

Oil-in-water emulsions are prepared using phospholipids purified from krill.

Growing community of inventors

Kolbotn, Norway

Stefan Hupfeld